Skip to main content

A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

Active, not recruiting · Phase 3 · NCT04232553

Conditions: Crohn's Disease

At a glance

Research payments reported, 2025
$1.1M
U.S. investigators named
51
Sites paid
50
Planned or actual enrollment
996

About the trial

Sponsor
Eli Lilly and Company
Tested
Mirikizumab (drug)
Dates
Started 2020-06-22; completion 2028-03
Results posted
Yes

The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.

From ClinicalTrials.gov, last updated 2026-08-11. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Eli Lilly and Company reported $1.1M in research payments for this study in 2025 (96 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Care Access Research LLC $118,358
  • Sfct A Member of the Alliance Inc $110,944
  • Washington Gastroenterology PLLC $70,388
  • Grand Teton Research Group PLLC $65,851
  • Delta Research PArtners LLC $49,720
  • Indiana University $45,959
  • Clinical Research of West Florida Inc $43,714
  • Tyler Research Institute LLC $43,610
  • Uh Cleveland Medical Center, OH $34,548
  • Calin Arimie MD $33,920
  • University of Virginia Medical Center, VA $30,476
  • Gastroenterology Associates of Orangeburg $27,895
  • Washington University $24,675
  • Southern Star Research Institute LLC $24,070
  • Clinical Research PArtners LLC $20,471
  • Connecticut Clinical Research Institute LLC $20,448
  • Noahs Ark Pediatrics $17,722
  • $17,170
  • Tpmg Rheumatology $15,324
  • Research Alliance Inc $15,263
  • Digestive Health Specialists $14,961
  • Woodholme Gastroenterology $14,781
  • Ezy Medical Research Co $14,272
  • Baylor College of Medicine $14,006
  • The Ohio State University $13,710
  • Univ of South Florida Rsrch Foundation $13,625
  • Precision Clinical Research LLC $13,132
  • Great Lakes Medical Research LLC $13,101
  • Mgg Group Corp Inc $12,409
  • Newport Huntington Medical Group $12,361
  • Ohio Gastroenterology Group Inc $12,316
  • Holy Name Medical Center $11,849
  • Board of Regents of the University of Oklahoma Health Sciences Center - Ouhsc, College of Medicine, $11,542
  • Caprock Gastro Research LLC $10,138
  • University Gastroenterology LLC $10,054
  • Digestive Healthcare of Georgia $9,909
  • Gastrointesinal Specialists of Georgia PC $8,826
  • Benaroya Research Institute at Virginia Mason $6,720
  • Minnesota Gastroenterology PA $6,523
  • Alliance Clinical Research of Tampa $6,376
  • Henry Ford Macomb Health Center $5,998
  • Hanson Clinical Research Center Inc. $3,070
  • University of Washington Medical Ctr, WA $877
  • North Portland Health Center $651
  • Cleveland Clinic, OH $264
  • Childrens Center for Digestive Health Care LLC $246
  • Gastroenterology Associates of Pesacola $236
  • University of Michigan Health System, MI $70
  • Arizona Arthritis and Rheumatology Research $70
  • Vancouver Clinic Inc Ps $70
  • Hoag Memorial Hospital Presbyterian $44

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.